{"id":904167,"date":"2025-11-03T10:01:32","date_gmt":"2025-11-03T15:01:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/"},"modified":"2025-11-03T10:01:32","modified_gmt":"2025-11-03T15:01:32","slug":"mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/","title":{"rendered":"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>RADNOR, Pa., Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the third quarter ended September 30, 2025, after the financial markets close on Monday, November 10, 2025.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"vertical-align: bottom\">\n            <strong>Monday, November 10th @ 4:30 p.m. ET<\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:12%;width:12%;min-width:12%;vertical-align: bottom\">Domestic:<\/td>\n<td style=\"max-width:88%;width:88%;min-width:88%;vertical-align: bottom\">1-877-704-4453<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">International:<\/td>\n<td style=\"vertical-align: bottom\">1-201-389-0920<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Conference ID:<\/td>\n<td style=\"vertical-align: bottom\">13756051<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Webcast:<\/td>\n<td style=\"vertical-align: bottom\">\n            <a href=\"https:\/\/viavid.webcasts.com\/starthere.jsp?ei=1736067&amp;tp_key=a4874c7d90\" rel=\"nofollow\" target=\"_blank\">Webcast Link<\/a>\n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        <br \/>A live webcast of the conference call may also be found on the \u201c<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Yy8ayCGyoVKTD3osya_dC32oO0OoPLCXDJsWc8MMQ1gGu5dWodO-I_WVSxQU-uQYftZIqpkAjgRAZXnLr0VQ055BmFIjtYj_NtrYKnQsxXE1gW_jArluvh0PDWY6jyDD\" rel=\"nofollow\" target=\"_blank\">News &amp; Events<\/a>\u201d page in the Investor Relations section of the Mineralys Therapeutics website.<\/p>\n<p>\n        <strong>About Mineralys Therapeutics<\/strong><br \/>\n        <br \/>Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as CKD, OSA and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7IWMn9h4_zsaVZ2Wboz9zVDzCV3d02jeyRovbMn78grKBt6Lg2Z9FnI1vLj2zZTAJvnVuHvyTFsURbW02nFb_SrRgn_GEGwCTmevOLywFo8=\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/mineralystx.com<\/u><\/a>. Follow Mineralys on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jiW82CpFiM-Kota9wiKKz_FCvFLf5ieKYXjlVHsmr0Lu3OWJAQUk3bjIZz_jFH8k-b_Vh-s1OSAYzoHAydyhyoI3AMe-l-jgYKMAvCWRtRXY7AbtyhHQ9hKqDYcE_JWmVIWtGhXJiZK1cpJRS2RVI42JYYVVCIh7qKEs3vf-aNc=\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oUv1FGnuJdLTYr5Zi8KLX5FgUdzAfOfila15qmCb0KZmbwNN-XgQoypVkgnUdBUrdt4jjI1PDRtxIS8QWBnH8zT1jhWppxeWAghSSN8XPkSx4DrQhgIdTkJ4-v8QDK_UVSKvywX_CROBrF6vFqjxCQ==\" rel=\"nofollow\" target=\"_blank\"><u>Twitter<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_SpQ1FVA29ryPR0_eApgSXWPZgas_oFcE3X-2ITPH_4JpXdb0B3U_kwPXdRyiIkmwIkLXlX0LZls-4Cbky7ng2N4fd8U22QaDVsrQzZ6hFE=\" rel=\"nofollow\" target=\"_blank\">Bluesky<\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Investor Relations <\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=V7hSpKTsviYR6nA69VzJIuqVciIc1LMCSUoqkjMVJITLJYbeXcaUP8Ycp412STK-nOA8Pg5vQStxjTqgNBsgt3YfUkDUCwoZQqJrR6C4ZlZOxP3cEHTkSYkhy9xYiX7ADlD5401M9HfqdN37Q6EGPw==\" rel=\"nofollow\" target=\"_blank\">investorrelations@mineralystx.com<\/a>\n      <\/p>\n<p>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>Melyssa Weible<br \/>Elixir Health Public Relations<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zOS_UTLjTdF24k1I5y3jhwoDk8Adj1ODbI-maWzBNEL-FB6lDyrdxxwF2l0EnP7iulVcnySAh4F4yyFwnWAY1mR2FqV9tRYPT4v-mjs7ZGBuHI1_1K3j5z9_jP9ajS1A\" rel=\"nofollow\" target=\"_blank\">mweible@elixirhealthpr.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDhiMjdmM2EtNDRjMy00MzRjLWIwYTgtOWNkYWU1NjQ5NmU3LTUwMDExMzcwMS0yMDI1LTExLTAzLWVu\/tiny\/Mineralys-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RADNOR, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the third quarter ended September 30, 2025, after the financial markets close on Monday, November 10, 2025. Monday, November 10th @ 4:30 p.m. ET Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13756051 Webcast: Webcast Link A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys Therapeutics Mineralys Therapeutics is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904167","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the third quarter ended September 30, 2025, after the financial markets close on Monday, November 10, 2025. Monday, November 10th @ 4:30 p.m. ET Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13756051 Webcast: Webcast Link A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys Therapeutics Mineralys Therapeutics is &hellip; Continue reading &quot;Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T15:01:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025\",\"datePublished\":\"2025-11-03T15:01:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/\"},\"wordCount\":214,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/\",\"name\":\"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==\",\"datePublished\":\"2025-11-03T15:01:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/","og_locale":"en_US","og_type":"article","og_title":"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 - Market Newsdesk","og_description":"RADNOR, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, today announced it will report its financial results from the third quarter ended September 30, 2025, after the financial markets close on Monday, November 10, 2025. Monday, November 10th @ 4:30 p.m. ET Domestic: 1-877-704-4453 International: 1-201-389-0920 Conference ID: 13756051 Webcast: Webcast Link A live webcast of the conference call may also be found on the \u201cNews &amp; Events\u201d page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys Therapeutics Mineralys Therapeutics is &hellip; Continue reading \"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T15:01:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025","datePublished":"2025-11-03T15:01:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/"},"wordCount":214,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/","name":"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==","datePublished":"2025-11-03T15:01:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Njk3NyM3MjM5MDQ0IzUwMDExMzcwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mineralys-therapeutics-to-announce-third-quarter-2025-financial-results-and-host-conference-call-on-monday-november-10-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904167"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904167\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}